In vivo enantioselectivity of epibatidine interaction with calcium-modulating drugs.
Several recent studies have implicated the involvement of calcium ion fluxes in the response to nicotine on a cellular level. The influence of a calcium agonist (BAY K 8644) and calcium blockers on (+)- and (-)-epibatidine-induced antinociception was investigated in mice using the tail-flick test. The effect of (+)-epibatidine but not (-)-epibatidine was significantly increased by BAY K 8644 pretreatment. This potentiation by BAY K 8644 was blocked by pretreating the animals with nifedipine at 2 mg/kg. The calcium channel antagonist, nimodipine, reduced significantly the antinociception induced by (+)-epibatidine but not (-)-epibatidine (12 microg/kg, s.c.). Similar results were also observed with the calcium chelator EGTA. Thus, epibatidine isomers pharmacological effect was differentially modulated by calcium signaling process secondary to receptor activation.